share_log

HC Wainwright & Co. Upgrades Kazia Therapeutics to Buy, Announces $2 Price Target

HC Wainwright & Co. Upgrades Kazia Therapeutics to Buy, Announces $2 Price Target

HC Wainwright & Co.將Kazia Therapeutics上調爲買入,宣佈2美元的目標
Benzinga ·  2023/04/11 06:21

HC Wainwright & Co. analyst Sean Lee upgrades Kazia Therapeutics (NASDAQ:KZIA) from Neutral to Buy and announces $2 price target.

HC Wainwright & Co. 分析師肖恩·李將Kazia Therapeutics(納斯達克股票代碼:KZIA)從中性上調至買入,並宣佈了2美元的目標股價

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論